Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

Similar articles for PubMed (Select 19466425)

1.

Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule.

Suzuki M, Hashizume M, Yoshida H, Mihara M.

Rheumatol Int. 2010 Jan;30(3):309-15. doi: 10.1007/s00296-009-0953-0. Epub 2009 May 23.

PMID:
19466425
2.

IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system.

Hashizume M, Hayakawa N, Suzuki M, Mihara M.

Rheumatol Int. 2009 Oct;29(12):1449-54. doi: 10.1007/s00296-009-0885-8. Epub 2009 Mar 7.

PMID:
19277666
3.

Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.

Matsumiya T, Imaizumi T, Fujimoto K, Cui X, Shibata T, Tamo W, Kumagai M, Tanji K, Yoshida H, Kimura H, Satoh K.

Exp Cell Res. 2001 Sep 10;269(1):35-41.

PMID:
11525637
4.
5.

Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions.

Lukacs NW, Strieter RM, Elner V, Evanoff HL, Burdick MD, Kunkel SL.

Blood. 1995 Oct 1;86(7):2767-73.

6.

Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.

Hashizume M, Mihara M.

Rheumatol Int. 2009 Feb;29(4):397-401. doi: 10.1007/s00296-008-0703-8. Epub 2008 Sep 20.

PMID:
18802703
7.

CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets.

Thienel U, Loike J, Yellin MJ.

Cell Immunol. 1999 Dec 15;198(2):87-95.

PMID:
10648122
8.
10.

Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.

Oh JW, Van Wagoner NJ, Rose-John S, Benveniste EN.

J Immunol. 1998 Nov 1;161(9):4992-9.

11.

Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells.

Morigi M, Zoja C, Figliuzzi M, Foppolo M, Micheletti G, Bontempelli M, Saronni M, Remuzzi G, Remuzzi A.

Blood. 1995 Apr 1;85(7):1696-703.

12.

IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts.

Marino M, Scuderi F, Provenzano C, Scheller J, Rose-John S, Bartoccioni E.

J Neuroimmunol. 2008 May 30;196(1-2):41-8. doi: 10.1016/j.jneuroim.2008.02.005. Epub 2008 Apr 8.

PMID:
18400310
13.

Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1.

Zoja C, Angioletti S, Donadelli R, Zanchi C, Tomasoni S, Binda E, Imberti B, te Loo M, Monnens L, Remuzzi G, Morigi M.

Kidney Int. 2002 Sep;62(3):846-56.

14.

IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor.

Nishimoto N, Ito A, Ono M, Tagoh H, Matsumoto T, Tomita T, Ochi T, Yoshizaki K.

Int Immunol. 2000 Feb;12(2):187-93.

15.
16.
17.

Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression.

Li FK, Davenport A, Robson RL, Loetscher P, Rothlein R, Williams JD, Topley N.

Kidney Int. 1998 Dec;54(6):2170-83.

18.

Cytokine regulation of CC and CXC chemokine expression by human astrocytes.

Oh JW, Schwiebert LM, Benveniste EN.

J Neurovirol. 1999 Feb;5(1):82-94.

PMID:
10190694
19.

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.

Mihara M, Kasutani K, Okazaki M, Nakamura A, Kawai S, Sugimoto M, Matsumoto Y, Ohsugi Y.

Int Immunopharmacol. 2005 Nov;5(12):1731-40.

PMID:
16102523
20.

Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N.

Arthritis Rheum. 2003 Jun;48(6):1521-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk